Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD von Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E

Volltext

Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized placebo-controlled double-blind, multi-dose study von VISICH, Jennifer E, ZUCKERMAN, Linda A, BUTINE, Michael D, GUNEWARDENA, Kulasiri A, WILD, Richard, MORTON, Kirsten M, REYNOLDS, Thomas C

Volltext

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency von Lovejoy, Amy E., Reynolds, Tom C., Visich, Jennifer E., Butine, Michael D., Young, Guy, Belvedere, Melissa A., Blain, Rachelle C., Pederson, Susan M., Ishak, Laura M., Nugent, Diane J.

Volltext

Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys von Dodds, Michael G, Visich, Jennifer E, Vicini, Paolo

Volltext

Preclinical Safety and Pharmacokinetics of Recombinant Human Factor XIII von Ponce, Rafael A., Visich, Jennifer E., Heffernan, Jane K., Lewis, Kenneth B., Pederson, Susan, Lebel, Elen, Andrews-Jones, Lydia, Elliott, Glenn, Palmer, Thomas E., Rogge, Mark C.

Volltext

Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers von Visich, Jennifer E., Zuckerman, Linda A., Butine, Michael D., Gunewardena, Kulasiri A., Wild, Richard, Morton, Kirsten M., Reynolds, Thomas C.

Volltext

Safety and pharmacokinetics of recombinant factor XIII-A2administration in patients with congenital factor XIII deficiency von LOVEJOY, Amy E, REYNOLDS, Tom C, VISICH, Jennifer E, BUTINE, Michael D, YOUNG, Guy, BELVEDERE, Melissa A, BLAIN, Rachelle C, PEDERSON, Susan M, ISHAK, Laura M, NUGENT, Diane J

Volltext

High-pressure liquid chromatographic assay for the determination of thyrotropin-releasing hormone and its common metabolites in a physiological salt solution circulated through the... von Visich, Jennifer E., Byron, Peter R.

Volltext

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development von Davis, John D., Bravo Padros, Marçal, Conrado, Daniela J., Ganguly, Samit, Guan, Xiaowen, Hassan, Hazem E., Hazra, Anasuya, Irvin, Susan C., Jayachandran, Priya, Kosloski, Matthew P., Lin, Kuan‐Ju, Mukherjee, Kamalika, Paccaly, Anne, Papachristos, Apostolos, Partridge, Michael A., Prabhu, Saileta, Visich, Jennifer, Welf, Erik S., Xu, Xiaoying, Zhao, An, Zhu, Min

Volltext

Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon von Li, Jing, Gupta, Manish, Jin, Denise, Xin, Yan, Visich, Jennifer, Allison, David E.

Volltext

Pharmacokinetics and Pharmacodynamics of Anti-BR3 Monoclonal Antibody in Mice von Marathe, Anshu, Iyer, Suhasini, Qiu, Zhihua Julia, Visich, Jennifer, Mager, Donald E.

Volltext

Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy von Zhu, Rui, Zheng, Yanan, Putnam, Wendy S., Visich, Jennifer, Eisner, Mark D., Matthews, John G., Rosen, Karin E., D’Argenio, David Z.

Volltext

Targeting Immune Complex-Mediated Hypersensitivity with Recombinant Soluble Human FcγRIA (CD64A) von Ellsworth, Jeff L., Maurer, Mark, Harder, Brandon, Hamacher, Nels, Lantry, Megan, Lewis, Kenneth B., Rene, Shirley, Byrnes-Blake, Kelly, Underwood, Sara, Waggie, Kimberly S., Visich, Jennifer, Lewis, Katherine E.

Volltext

Preclinical safety of recombinant human thrombin von Heffernan, Jane K., Ponce, Rafael A., Zuckerman, Linda A., Volpone, John P., Visich, Jennifer, Giste, Erika E., Jenkins, Nancy, Boster, Dan, Pederson, Susan, Knitter, Glenn, Palmer, Thomas, Wills, Margaret, Early, Richard J., Rogge, Mark C.

Volltext

Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A) von Ellsworth, Jeff L, Maurer, Mark, Harder, Brandon, Hamacher, Nels, Lantry, Megan, Lewis, Kenneth B, Rene, Shirley, Byrnes-Blake, Kelly, Underwood, Sara, Waggie, Kimberly S, Visich, Jennifer, Lewis, Katherine E

Volltext

Targeting Immune Complex-Mediated Hypersensitivity with Recombinant Soluble Human Fc{gamma}RIA (CD64A) von Ellsworth, Jeff L, Maurer, Mark, Harder, Brandon, Hamacher, Nels, Lantry, Megan, Lewis, Kenneth B, Rene, Shirley, Byrnes-Blake, Kelly, Underwood, Sara, Waggie, Kimberly S, Visich, Jennifer, Lewis, Katherine E

Volltext

Utilización de la proteína de fusión TACI-Ig, tal como atacicept, para la fabricación de un medicamento para el tratamiento de lupus eritematoso von NESTOROV, Ivan, PAPASOULIOTIS, Orestis, MUNAFO, Alain, VISICH, Jennifer, PENA ROSSI, Claudia, GROSS, Jane A, BUSBY, Sharon J

Volltext bestellen

métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig von HERVE BROLY, IVAN NESTOROV, SHARON BUSBY, JANE GROSS, JENNIFER VISICH

Volltext bestellen